Certificate u/r 74(5) for the quarter ended June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samrat Pharmachem Limited has submitted a routine compliance certificate under SEBI Regulation 74(5) to BSE for the quarter ended June 30, 2025. The certificate, issued by the company's Registrar and Transfer Agent (RTA), MUFG Intime India Pvt. Ltd., confirms that all share dematerialisation requests received from depository participants during the quarter were properly processed, accepted or rejected, and the corresponding physical certificates were mutilated and cancelled. The RTA also confirms that the depositories' names have been substituted as registered owners in the company's member register within the required timelines. This is a standard quarterly compliance requirement with no material business activity disclosed.
This is a routine procedural filing with no impact on the company's financials, operations, or shareholder value. It simply demonstrates regulatory compliance regarding share demat processing.